Cosmos Health Inc. · NASDAQ:COSM
Cosmos Health — Investor Presentation (October 2022)
18 slides from Cosmos Health's investor presentation, October 2022
Slide 1: Cosmos Holdings Inc. Company Presentation October 2022
COSMOS HOLDINGS INC. (NASDAQ: COSM) OCTOBER 2022 COMPANY PRESENTATION
Slide 2: Disclaimer
DISCLAIMER This presentation is not an offer to sell securities, nor is it a solicitation of an offer to buy securities in any locality, state, country or other jurisdiction where such distribution, publication, availability or use would be contrary to law or regulation, or which would require any reg
Slide 3: Cosmos Health at a Glance
2009 Cosmos Health was founded Global HQ in Chicago, IL, US and offices in Thessaloniki, Greece, Athens, Greece, Harlow, UK Cosmos Health at a Glance Uplisting February 28, 2022 (Nasdaq: COSM) Our mission is to improve people’s lives. 95 Employees as of December 31, 2021 $56.2M FY’21 revenue 3
Slide 4: Cosmos Health: An International Healthcare Group
COSMOS HEALTH AN INTERNATIONAL HEALTHCARE GROUP Who we are What we do How we do it • We are Cosmos Health, an • We develop and distribute our own • We prioritize our customers’ needs, international healthcare group. proprietary line of nutraceuticals as focusing on the latest scientific well as a br
Slide 5: Our Strategy
OUR STRATEGY Our focus is high We use our extended margin nutraceuticals network to gain and R&D efforts to access to new develop IP products markets and business segments. Diversification allows us to exploit new opportunities and synergies while minimizing risk. 5
Slide 6: The Team
THE TEAM Greg Siokas Pavlos Ignatiades George Terzis Chief Executive Officer Chief Operating Officer Chief Financial Officer Greg Siokas has over 20 years of experience in the Pavlos Ignatiades has been a senior portfolio manager George Terzis oversees all Cosmos’ financial pharma industry. He has w
Slide 7: Cosmos Group Overview
COSMOS GROUP OVERVIEW • Corporate Office in the Chicago • Office area of 850m2, fully • State of the art GDP warehouse, • Warehouse area of 400m2, Board of Trade Building,141 West equipped & air-conditioned of total surface area of 2,900m2, licensed under GDP with Jackson Blvd, Chicago, Illinois. •
Slide 8: Market Analysis
MARKET ANALYSIS Nutraceuticals Pharmaceuticals Healthcare Distribution ❖ Global Nutraceuticals Market was valued at ❖ The Global Pharmaceuticals Market is expected to ❖ Global Healthcare Distribution Market was valued $455bn in 2021 and is expected to reach grow from $1,455bn in 2021 to $1,587 in 20
Slide 9: Our Business Model
OUR BUSINESS MODEL Nutraceuticals Pharmaceuticals Healthcare Distribution • “Sky Premium Life” and “Mediterranation” • Exclusivity on medicine licenses of fast-moving • Direct distribution and sales of pharmaceuticals, high-end brands of premium nutraceuticals product codes medical devices, generics
Slide 10: Our Sale Channels / Our Partners
OUR SALE CHANNELS OUR PARTNERS 10
Slide 11: Development of New Products & Product Lines
DEVELOPMENT OF NEW PRODUCTS & PRODUCT LINES Eleonas Chios Mastic Mediterranation • Sage, mint, basil, sideritis extracts in • Chios mastic organic extra virgin olive oil • Inulin • Vitamins E, K2, D3 • Digestive system support • Cardiovascular system support and antioxidant action Olympus Mons Chios
Slide 12: Gut Microbiome-Based R&D
GUT MICROBIOME-BASED R&D Food Supplements Medical Devices FSMPs Pharmaceuticals Medical Fields Collaborations ❖ Bone remodeling ❖ Weight management ❖ IBD/ Chron Disease ❖ Metabolic syndrome 12
Slide 13: Key Milestones
KEY MILESTONES 05 Uplisting to Nasdaq Stock Exchange Q1 2022 07 Launch of nutraceutical brand 01 Acquisition of 03 Launch of Mediterranation Decahedron Ltd in UK nutraceutical brand Q2 2022 Q2 2017 Sky Premium Life Q4 2019 2017 2018 2019 2020 2022 08 Change of name from 06 Strategic Cosmos partnersh
Slide 14: Key – Recent 2022 Events
KEY – RECENT 2022 EVENTS Date Description Feb 28, 2022 Cosmos Health announced Nasdaq Uplisting and concurrent private placement. Launch of: ▪ Sky Premium Life Prostatium supplement for prostate health and Brainlit supplement for brain health. Mar 28-Apr 12, 2022 ▪ New premium nutritional supplement
Slide 15: Key Figures
KEY FIGURES Financial Highlights H1 2022 Trading data (10/04/2022) Capital Structure (06/30/2022) Adjusted EBITDA Stock price # of $ % of Fully Security WAEP Shares Value Diluted $1.1 million $0.19 Common Shares Outstanding 23,998,872 $8,879,583 47.75% $26.3 million $5.1 million Total revenue Market
Slide 16: Market Data - Comparable Companies
MARKET DATA - COMPARABLE COMPANIES Operating Statistics Capitalization Financial Metrics Company Market Enterprise Revenue EBITDA Ticker Market Cap / Revenue Market Cap / EBITDA Name Cap Value (TTM) (TTM) RVLP RVL Pharmaceuticals plc $208.22 $224.08 $34.95 N/M 5.96x N/M CDXC ChromaDex Corporation $8
Slide 17: Why to Invest in Cosmos Health?
WHY TO INVEST IN COSMOS HEALTH ? ❖ Significantly Undervalued Company ❖ Proven Revenue Growth Track record ❖ Well-positioned in the Marketplace with Established Sales Networks ❖ Innovative Nutraceutical Products based on extended R&D efforts ❖ Unique A to Z Business Model that distinguish us from com
Slide 18: Thank You
THANK YOU 141 West Jackson Blvd., Suite 4236 Chicago, IL 60604 [email protected] (US) +1 312 536 3102
Cosmos Holdings Inc. (Cosmos Health) — Investor Presentation (October 2022) on 6ix